Yoruba
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message
Awọn ẹka Awọn ọja
Awọn ẹka Awọn ọja

FDA DMF Awọn ọja ti o kun

GMP-TL101 Anti-Human CD3 mAb idanimọ Antigen, iyipada ifihan ati imuṣiṣẹ sẹẹli TGMP-TL101 Anti-Human CD3 mAb idanimọ Antigen, iyipada ifihan ati imuṣiṣẹ sẹẹli T
01

GMP-TL101 Anti-Human CD3 mAb idanimọ Antigen, iyipada ifihan ati imuṣiṣẹ sẹẹli T
2024-06-29

Iṣura: Ninu Iṣura
Awoṣe: GMP-TL101

wo apejuwe awọn
Anti-Eniyan CD28 mAb GMP-TL102 Ṣe okunfa iyatọ sẹẹli T ati afikunAnti-Eniyan CD28 mAb GMP-TL102 Ṣe okunfa iyatọ sẹẹli T ati afikun
01

Anti-Eniyan CD28 mAb GMP-TL102 Ṣe okunfa iyatọ sẹẹli T ati afikun
2024-06-29

Iṣura: Ninu Iṣura
Awoṣe: GMP-TL102

wo apejuwe awọn